How Does the 2026 Cyclospora Outbreak Affect Gastroenterology Billing?
As of August 13, 2026, the CDC has confirmed 13,895 domestically acquired cases of cyclosporiasis across multiple states, compared to 1,180 cases at the same point in 2025. The outbreak has been linked to contaminated iceberg lettuce from Taylor Farms de Mexico, with a nationwide recall issued July 17, 2026. For gastroenterology practices, this surge means a sharp increase in patients presenting with prolonged watery diarrhea, weight loss, and bloating, and every one of those encounters carries coding, testing, and billing requirements that must be handled correctly to avoid denials.
ICD-10 code A07.4: Cyclosporiasis is reported under A07.4 (Cyclosporiasis). Using a general diarrhea code such as R19.7 or K59.1 instead of the specific parasitic diagnosis code will trigger medical necessity denials on stool testing and repeat visits.
Stool testing requires multiple specimens: Cyclospora oocyst shedding is intermittent, so the CDC recommends multiple stool samples. Each specimen collection and analysis must be coded and billed separately, using CPT 87177 (ova and parasites, concentration) or the appropriate molecular panel code.
Documentation drives reimbursement: E/M visits for GI symptoms during this outbreak require documentation linking the clinical presentation to the suspected parasitic etiology, travel or food exposure history, and the rationale for repeat testing when the first specimen is negative.
What Happened: The 2026 Outbreak
The CDC began tracking an unusual spike in cyclosporiasis cases in May 2026. By mid-July, the agency had confirmed that contaminated iceberg lettuce processed by Taylor Farms de Mexico was the source of a multistate outbreak. Taylor Farms issued a voluntary recall on July 17, 2026. The contaminated lettuce had been sold at retail stores and served in restaurants, including Taco Bell locations, where the CDC analyzed food exposure data from 190 confirmed cases.
The numbers are staggering by historical standards. The CDC reported 13,895 confirmed domestic cases as of August 13, 2026. At the same point in 2025, only 1,180 cases had been reported nationwide. Michigan alone has reported nearly 14,000 cases including at least 314 hospitalizations and 2 deaths. The CDC has noted that the true case count is likely higher because many people recover without seeking medical care or being tested.
For GI practices in the affected states, this outbreak is not abstract. Patients are presenting with prolonged watery diarrhea lasting weeks, loss of appetite, significant weight loss, bloating, nausea, and fatigue. These symptoms overlap with irritable bowel syndrome, inflammatory bowel disease flares, and other chronic GI conditions, making differential diagnosis and accurate coding even more important. One question we hear constantly from practice managers during outbreak events like this is whether the visit codes and testing codes are being captured correctly when the volume spikes.
How Should GI Practices Code Cyclosporiasis?
The correct ICD-10-CM code for cyclosporiasis is A07.4 (Cyclosporiasis). This code sits in the A07 category (Other protozoal intestinal diseases) and must be used as the primary diagnosis when the clinical picture supports a Cyclospora infection. Using nonspecific symptom codes like R19.7 (Diarrhea, unspecified) or K52.9 (Noninfective gastroenteritis, unspecified) instead of A07.4 is the fastest way to generate a medical necessity denial on the stool testing you ordered to confirm the diagnosis.
Before the diagnosis is confirmed, code the presenting symptoms. An initial visit where the patient presents with prolonged watery diarrhea and the provider orders stool testing should use the symptom code (R19.7 or the clinically appropriate symptom) on the first encounter. Once stool microscopy or a molecular panel confirms Cyclospora, all subsequent encounters and any repeat testing should be coded under A07.4.
The table below maps the most common coding scenarios during the outbreak.
| Clinical Scenario | Primary ICD-10 Code | Notes |
| Initial visit, suspected Cyclospora | R19.7 (Diarrhea, unspecified) or R10.9 with symptoms | Use symptoms until lab confirms |
| Confirmed cyclosporiasis | A07.4 (Cyclosporiasis) | Switch after positive stool result |
| Relapsing symptoms after treatment | A07.4 with Z87.19 (history of infectious disease) | Supports repeat testing |
| Dehydration requiring IV fluids | A07.4 + E86.0 (Dehydration) | Captures severity for higher E/M level |
| Hospitalization for severe illness | A07.4 as principal diagnosis | 9% of CDC-reported cases required hospitalization |
Which Stool Tests Should GI Practices Bill?
Cyclospora diagnosis requires stool microscopy with special staining (modified acid-fast or safranin staining) to identify oocysts. Standard ova and parasite exams may miss Cyclospora if the lab does not specifically look for it, and the parasite sheds intermittently, which is why the CDC recommends collecting multiple stool specimens over several days.
The primary CPT codes for stool testing in the context of this outbreak are:
1. CPT 87177 (Ova and parasites, smear, concentration and identification): This is the standard stool parasitology exam. Bill this for each specimen submitted. When three stool samples are collected on different dates, each one is billed as a separate 87177. Payers expect separate dates of service for repeat specimens, not a single date with multiple units.
2. CPT 87207 (Smear, special stain for inclusion bodies or parasites): Bill this when the laboratory performs modified acid-fast or safranin staining specifically to identify Cyclospora oocysts. This may be billed in addition to 87177 when a special stain is performed beyond the routine concentration exam.
3. Molecular or multiplex GI panel (CPT 87505, 87506, or 87507): Some laboratories use syndromic GI panels that detect Cyclospora via PCR. If your lab runs a panel such as the BioFire FilmArray GI Panel, the panel code is billed once per specimen. Check with your lab to confirm whether their panel includes Cyclospora as a target.
Across the billing companies we vet, the most common error during outbreak surges is billing repeat stool tests on the same date of service or failing to link the test to the specific parasitic diagnosis code. Each specimen must be collected on a separate date and linked to A07.4 or the appropriate symptom code to establish medical necessity for the repeat order.
If your GI practice is seeing a spike in patients with prolonged watery diarrhea this summer, your billing workflow needs to capture every encounter, test, and follow-up visit correctly. A billing partner with experience in gastroenterology coding ensures that outbreak-related volume does not turn into outbreak-related denials.
What E/M Documentation Does This Outbreak Require?
Evaluation and management visits for patients presenting with suspected or confirmed cyclosporiasis should document three things that directly affect coding and reimbursement.
First, document the exposure history. The CDC has linked this outbreak to contaminated iceberg lettuce. Ask the patient whether they consumed fresh produce, ate at a restaurant, or traveled domestically in the 2 to 14 days before symptom onset. This exposure history supports the medical decision-making complexity and justifies the workup.
Second, document the clinical timeline. Cyclospora symptoms typically begin about 7 days after exposure but can range from 2 to 14 days. Symptoms often last weeks if untreated and can relapse. A clear timeline in the note distinguishes a new parasitic infection from a flare of a chronic GI condition, which is the differential that payers will question if modifier usage or E/M level is challenged.
Third, document the rationale for repeat testing. Because Cyclospora sheds intermittently, a negative first stool sample does not rule out infection. If you order a second or third specimen, the note must explain why: ongoing symptoms consistent with cyclosporiasis despite a negative initial O&P, intermittent shedding pattern requiring multiple specimens per CDC guidance. Without that rationale, the repeat test will be denied as duplicative.
Providers often come to us after a denial wave and the root cause is almost always the same: the clinical note supported the work, but the documentation did not explicitly state the reasoning in a way the payer’s reviewer could follow. During an outbreak, when visit volume spikes and providers move fast, documentation shortcuts are the first thing that creates billing problems.
Common Billing Mistakes During GI Outbreaks
1. Using a nonspecific diarrhea code after diagnosis is confirmed. Once stool testing confirms Cyclospora, all subsequent visits and testing must use A07.4. Continuing to bill under R19.7 after a confirmed result understates the diagnosis and triggers denials on follow-up care.
2. Billing multiple stool specimens on the same date of service. Each O&P specimen should be collected on a separate date. Billing three units of 87177 on a single date of service will be denied by most payers as not medically necessary. The CDC guidance calls for specimens collected over several days.
3. Missing the dehydration code on high-acuity visits. Nine percent of CDC-reported cases required hospitalization, often for dehydration. If you administer IV fluids or manage electrolyte imbalances, code E86.0 (Dehydration) as a secondary diagnosis. This supports the medical decision-making complexity and, for inpatient cases, affects the DRG assignment.
4. Failing to document why a GI panel was ordered instead of a targeted O&P. Multiplex GI panels are more expensive than a single O&P exam. Payers may question medical necessity if the note does not explain why a broad panel was needed. During an active outbreak, the rationale is straightforward: the differential includes bacterial, viral, and parasitic causes, and a panel covers all three in a single specimen. State that reasoning in the note.
5. Not checking whether your modifier 52 in medical billing applies to a reduced stool workup. If your lab performs a limited parasitology exam rather than the full concentration and identification, modifier 53 for a discontinued procedure or modifier 52 may apply depending on the clinical circumstances. Applying the wrong modifier or omitting it entirely leads to payment discrepancies.
When to Refer and When to Treat In-House
Most cyclosporiasis cases resolve with a 7-day course of trimethoprim-sulfamethoxazole (TMP-SMX), which primary care providers can prescribe. GI referral is appropriate when symptoms persist beyond two weeks despite treatment, when the patient has a sulfa allergy requiring an alternative regimen, when dehydration is severe enough to require IV management, or when the differential includes IBD or another chronic GI condition that needs endoscopic evaluation.
For GI practices, the revenue opportunity during this outbreak is not in treating every diarrhea case. It is in providing the diagnostic expertise that primary care cannot: differentiating Cyclospora from IBD flares, celiac disease presentations, or microscopic colitis in patients with overlapping symptom profiles. The E/M level for these complex differential diagnoses is higher than a straightforward infection visit, and the documentation should reflect that complexity.
If your practice uses modifier 33 for preventive services in medical billing, be aware that a colonoscopy performed to rule out IBD in a patient initially presenting with Cyclospora-like symptoms is a diagnostic procedure, not a screening. The distinction matters for both coding and patient cost-sharing.
Frequently Asked Questions
What is the ICD-10 code for cyclosporiasis?
The correct code is A07.4 (Cyclosporiasis). Use this as the primary diagnosis once stool testing confirms the infection. Before confirmation, code the presenting symptom such as R19.7 for unspecified diarrhea. Using the specific parasitic code supports medical necessity for stool testing and follow-up visits.
How many stool samples are needed to diagnose Cyclospora?
The CDC recommends multiple stool specimens collected on separate days because Cyclospora oocyst shedding is intermittent. A single negative stool sample does not rule out infection. Each specimen is billed separately under CPT 87177, and the clinical note must document why repeat testing was ordered.
Can a GI multiplex panel detect Cyclospora?
Some multiplex panels, such as the BioFire FilmArray GI Panel, include Cyclospora as a target organism. Check with your laboratory to confirm coverage. If the panel detects Cyclospora, the result supports coding under A07.4. The panel is billed under CPT 87505, 87506, or 87507 depending on the number of targets.
Is cyclosporiasis a reportable condition?
Yes. Cyclosporiasis is a nationally notifiable condition. Laboratories and providers in most states are required to report confirmed cases to their state health department. During the 2026 outbreak, reporting supports the CDC’s traceback investigation and helps identify contaminated food sources.
How long do cyclosporiasis symptoms last?
Untreated, symptoms can persist for weeks to months and may relapse. With appropriate antibiotic treatment (typically TMP-SMX for 7 days), most patients improve within a few days. Relapsing symptoms after treatment completion may require a second course and additional stool testing, both of which are billable with proper documentation.
What happens if a patient has a sulfa allergy?
There is no well-established alternative to TMP-SMX for cyclosporiasis. The CDC recommends consulting an infectious disease specialist for patients with sulfa allergies. From a billing perspective, an infectious disease referral generates a separate E/M encounter that should be coded under A07.4 with the appropriate allergy code documented.
Should GI practices expect more Cyclospora cases this summer?
The CDC considers May through August the cyclosporiasis season. The 2026 outbreak is already more than 11 times larger than the same period in 2025. While the Taylor Farms recall has been issued, cases may continue to be reported through September due to the lag between exposure, symptom onset, and laboratory confirmation.
How does this affect GI practice revenue?
Each Cyclospora patient encounter generates E/M revenue, stool testing charges, and potentially IV hydration or follow-up visit revenue. For practices that capture the coding correctly, including the specific A07.4 diagnosis, separate-date stool specimens, and documented medical decision-making complexity, the outbreak represents legitimate clinical volume that should be billed and reimbursed without denials.
Next Steps
If your GI practice is in one of the affected states, confirm with your laboratory that their stool parasitology protocol includes Cyclospora-specific staining. Update your coding templates to include A07.4 and the associated stool testing CPT codes.
If outbreak-related visit volume is straining your billing workflow, or if you are seeing an uptick in stool-testing denials, this is a practical time to evaluate whether your billing setup is equipped for the surge.
Gastroenterology Billing connects GI practices with billing companies that understand outbreak-related coding complexity, stool testing workflows, and the documentation that keeps parasitic infection claims clean. The matching process is free and takes as little as 30 minutes.
